VVOS - Why Is Sleep Disorder Device Provider Vivos Therapeutics Stock Trading Higher Today? | Benzinga
Vivos Therapeutics Inc (NASDAQ: VVOS) received FDA 510(k) clearance for treating severe obstructive sleep apnea (OSA) in adults using the Vivos' removable CARE (Complete Airway Repositioning and/or Expansion) oral appliances.
Vivos' CARE appliances include the flagship DNA oral appliance, the mRNA oral appliance, and the mmRNA oral appliance.
As a result of this FDA clearance, Vivos became the first company ever to have approved and bring to market a clear ...